142 related articles for article (PubMed ID: 3338635)
21. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
Fletcher MP; Stahl GL; Longhurst JC
J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
[TBL] [Abstract][Full Text] [Related]
22. Enteropathogenic Escherichia coli: stimulating neutrophil migration across a cultured intestinal epithelium without altering transepithelial conductance.
Michail SK; Halm DR; Abernathy F
J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):253-60. PubMed ID: 12548063
[TBL] [Abstract][Full Text] [Related]
23. The blockade of formyl peptide-induced respiratory burst by 2',5'-dihydroxy-2-furfurylchalcone involves phospholipase D signaling in neutrophils.
Wang JP; Chang LC; Hsu MF; Lin CN
Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):166-74. PubMed ID: 12928764
[TBL] [Abstract][Full Text] [Related]
24. Formyl-methionyl-leucyl-phenylalanine causes bronchoconstriction in rabbits.
Berend N; Armour CL; Black JL
Agents Actions; 1986 Mar; 17(5-6):466-71. PubMed ID: 3706051
[TBL] [Abstract][Full Text] [Related]
25. Haematological effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in man.
Peters MJ; Breslin AB; Kemp AS; Chu J; Berend N
Thorax; 1992 Apr; 47(4):284-7. PubMed ID: 1585293
[TBL] [Abstract][Full Text] [Related]
26. Oleuropein and hydroxytyrosol inhibit the N-formyl-methionyl-leucyl-phenylalanine-induced neutrophil degranulation and chemotaxis via AKT, p38, and ERK1/2 MAP-Kinase inhibition.
Bedouhene S; Moulti-Mati F; Dang PM; El-Benna J
Inflammopharmacology; 2017 Dec; 25(6):673-680. PubMed ID: 28711992
[TBL] [Abstract][Full Text] [Related]
27. C-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs.
Abernathy VJ; Webster RO; Dahms TE
Am J Physiol; 1996 Aug; 271(2 Pt 2):H507-13. PubMed ID: 8770090
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of protein kinase C, mitogen-activated protein kinase, and neutrophil activation in response to calcium pyrophosphate dihydrate crystals, formyl-methionyl-leucyl-phenylalanine, and phorbol ester by O-(chloroacetyl-carbamoyl) fumagillol (AGM-1470; TNP-470).
Tudan C; Jackson JK; Pelech SL; Attardo G; Burt H
Biochem Pharmacol; 1999 Dec; 58(12):1869-80. PubMed ID: 10591141
[TBL] [Abstract][Full Text] [Related]
29. Ileal mucosal response to bacterial toxin challenge.
Harari Y; Weisbrodt NW; Moody FG
J Trauma; 2000 Aug; 49(2):306-13. PubMed ID: 10963544
[TBL] [Abstract][Full Text] [Related]
30. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
[TBL] [Abstract][Full Text] [Related]
31. Contrasting effects of two arachidonate 5-lipoxygenase inhibitors on formyl-methionyl-leucyl-phenylalanine (fMLP) and complement fragment 5a induced human neutrophil superoxide generation.
Kocan GP; Partis RA; Mueller RA; Smith WG; Nakao A
Biochem Pharmacol; 1994 Mar; 47(6):1029-37. PubMed ID: 8147901
[TBL] [Abstract][Full Text] [Related]
32. Microvascular pressure and albumin extravasation after leukocyte activation in hamster cheek pouch.
Gawlowski DM; Benoit JN; Granger HJ
Am J Physiol; 1993 Feb; 264(2 Pt 2):H541-6. PubMed ID: 7680539
[TBL] [Abstract][Full Text] [Related]
33. Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's disease.
Anton PA; Targan SR; Shanahan F
Gastroenterology; 1989 Jul; 97(1):20-8. PubMed ID: 2542118
[TBL] [Abstract][Full Text] [Related]
34. Aroclor 1242 stimulates the production of inositol phosphates in polymorphonuclear neutrophils.
Tithof PK; Contreras ML; Ganey PE
Toxicol Appl Pharmacol; 1995 Mar; 131(1):136-43. PubMed ID: 7878669
[TBL] [Abstract][Full Text] [Related]
35. Alteration of cellular cytosolic calcium and chemotactic peptide binding by an inhibitor of neutrophil function.
Cooper JA; Bridges TA; Kennedy JI; Culbreth R
Am J Physiol; 1994 Jul; 267(1 Pt 1):L71-8. PubMed ID: 8048544
[TBL] [Abstract][Full Text] [Related]
36. Inhaled FMLP increases microvascular permeability in the rabbit trachea.
Bell SC; Rynell AC; Matheson MJ; Finnimore AJ; Berend N
J Appl Physiol (1985); 1993 Mar; 74(3):1337-41. PubMed ID: 8482675
[TBL] [Abstract][Full Text] [Related]
37. Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils.
Coëffier E; Joseph D; Prévost MC; Vargaftig BB
Br J Pharmacol; 1987 Oct; 92(2):393-406. PubMed ID: 3118996
[TBL] [Abstract][Full Text] [Related]
38. N-formyl-methionyl-leucyl-phenylalanine (fMLP) inhibits tumour necrosis factor-alpha (TNF-alpha) production on lipopolysaccharide (LPS)-stimulated human neutrophils.
Vulcano M; Alves Rosa MF; Minnucci FS; Cherñavsky AC; Isturiz MA
Clin Exp Immunol; 1998 Jul; 113(1):39-47. PubMed ID: 9697981
[TBL] [Abstract][Full Text] [Related]
39. 2-Benzyloxybenzaldehyde inhibits formyl-methionyl-leucyl-phenylalanine stimulation of phospholipase D activation in rat neutrophils.
Wang JP; Chang LC; Hsu MF; Huang LJ; Kuo SC
Biochim Biophys Acta; 2002 Oct; 1573(1):26-32. PubMed ID: 12383938
[TBL] [Abstract][Full Text] [Related]
40. Surfactant protein A differentially regulates peripheral and inflammatory neutrophil chemotaxis.
Schagat TL; Wofford JA; Greene KE; Wright JR
Am J Physiol Lung Cell Mol Physiol; 2003 Jan; 284(1):L140-7. PubMed ID: 12388367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
